Company Filing History:
2 out of 445 
2 out of 1,211 
2 out of 2,898 
Years Active: 2020-2023
Title: **Mark Kendell Clement: Innovator in Cancer Diagnostics and Treatment**
Introduction
Mark Kendell Clement, based in Cambridge, MA, is an accomplished inventor recognized for his significant contributions to the field of cancer research. With a focus on utilizing molecular biology techniques to enhance cancer diagnostics and therapeutics, he holds two patents that demonstrate his innovative approach to cancer treatment.
Latest Patents
Clement's most recent patents revolve around "Compositions and methods for diagnosing, evaluating, and treating cancer by means of the DNA methylation status." This invention encompasses methods for determining cancer treatment prognosis by assessing epigenetic and genetic changes within tumor samples. Additionally, it provides novel methodologies for treating cancer by evaluating these changes, and includes strategies for screening test agents to identify those that decrease tumor cell plasticity. These patents highlight his dedication to advancing cancer care through targeted and precise interventions.
Career Highlights
Throughout his career, Mark Kendell Clement has made impactful contributions while working at prestigious institutions, including the Broad Institute and Dana-Farber Cancer Institute. His tenure at these organizations underscores his commitment to cancer research and the development of innovative solutions to address complex medical challenges.
Collaborations
Clement has collaborated with notable coworkers such as Gad Getz and Dan-Avi Landau. These partnerships have facilitated a collaborative environment that fosters innovation and the exchange of ideas, enhancing the overall impact of their research efforts.
Conclusion
Mark Kendell Clement stands out as an influential inventor in the field of cancer diagnostics and treatment. His patents not only underscore his innovative spirit but also highlight the potential for significant advancements in cancer care through his research. With a robust career trajectory and valuable collaborations, Clement continues to pave the way for future breakthroughs in oncology.